Literature DB >> 23128394

Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression.

A Pagliuca1, C Valvo, E Fabrizi, S di Martino, M Biffoni, D Runci, S Forte, R De Maria, L Ricci-Vitiani.   

Abstract

MicroRNAs (miRNAs) from the gene cluster miR-143-145 are diminished in cells of colorectal tumor origin when compared with normal colon epithelia. Until now, no report has addressed the coordinate action of these miRNAs in colorectal cancer (CRC). In this study, we performed a comprehensive molecular and functional analysis of the miRNA cluster regulatory network. First, we evaluated proliferation, migration, anchorage-independent growth and chemoresistance in the colon tumor cell lines after miR-143 and miR-145 restoration. Then, we assessed the contribution of single genes targeted by miR-143 and miR-145 by reinforcing their expression and checking functional recovery. Restoring miR-143 and miR-145 in colon cancer cells decreases proliferation, migration and chemoresistance. We identified cluster of differentiation 44 (CD44), Kruppel-like factor 5 (KLF5), Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) and v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) as proteins targeted by miR-143 and miR-145. Their re-expression can partially revert a decrease in transformation properties caused by the overexpression of miR-143 and miR-145. In addition, we determined a set of mRNAs that are diminished after reinforcing miR-143 and miR-145 expression. The whole transcriptome analysis ascertained that downregulated transcripts are enriched in predicted target genes in a statistically significant manner. A number of additional genes, whose expression decreases as a direct or indirect consequence of miR-143 and miR-145, reveals a complex regulatory network that affects cell signaling pathways involved in transformation. In conclusion, we identified a coordinated program of gene repression by miR-143 and miR-145, in CRC, where either of the two miRNAs share a target transcript, or where the target transcripts share a common signaling pathway. Major mediators of the oncosuppression by miR-143 and miR-145 are genes belonging to the growth factor receptor-mitogen-activated protein kinase network and to the p53 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23128394     DOI: 10.1038/onc.2012.495

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  90 in total

1.  The effect of recombinant lentiviral vector encoding miR-145 on human esophageal cancer cells.

Authors:  Tian-Yun Wang; Qing-Qing Zhang; Xi Zhang; Qiu-Li Sun; Chun-Peng Zhao; Xiao-Yin Wang
Journal:  Tumour Biol       Date:  2015-07-09

2.  A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma.

Authors:  Osamu Maehara; Fumiyuki Sato; Mitsuteru Natsuizaka; Ayaka Asano; Yoshimasa Kubota; Jun Itoh; Seiji Tsunematsu; Katsumi Terashita; Yoko Tsukuda; Masato Nakai; Takuya Sho; Goki Suda; Kenichi Morikawa; Koji Ogawa; Makoto Chuma; Koji Nakagawa; Shunsuke Ohnishi; Yoshito Komatsu; Kelly A Whelan; Hiroshi Nakagawa; Hiroshi Takeda; Naoya Sakamoto
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

Review 3.  miRNAs derived from cancer-associated fibroblasts in colorectal cancer.

Authors:  Amir Savardashtaki; Zahra Shabaninejad; Ahmad Movahedpour; Roxana Sahebnasagh; Hamed Mirzaei; Michael R Hamblin
Journal:  Epigenomics       Date:  2019-11-08       Impact factor: 4.778

4.  miR-221 regulates CD44 in hepatocellular carcinoma through the PI3K-AKT-mTOR pathway.

Authors:  Jihye Kim; Jinmai Jiang; Mohamed Badawi; Thomas D Schmittgen
Journal:  Biochem Biophys Res Commun       Date:  2017-04-23       Impact factor: 3.575

5.  miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition.

Authors:  Hong Zhao; Xing Kang; Xuefeng Xia; Like Wo; Xidong Gu; Yuanyuan Hu; Xiaohong Xie; Helena Chang; Lihua Lou; Xuning Shen
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

6.  Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.

Authors:  G Liang; Y Zhu; A Jing; J Wang; F Hu; W Feng; Z Xiao; B Chen
Journal:  Gene Ther       Date:  2016-08-02       Impact factor: 5.250

7.  Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma.

Authors:  X Zhang; Y Zhang; J Yang; S Li; J Chen
Journal:  Cancer Gene Ther       Date:  2015-09-18       Impact factor: 5.987

Review 8.  Study of apoptosis-related interactions in colorectal cancer.

Authors:  Himanshu Arora; Rehana Qureshi; M A Rizvi; Sharad Shrivastava; Mordhwaj S Parihar
Journal:  Tumour Biol       Date:  2016-09-15

Review 9.  Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

Authors:  Yoshinaga Okugawa; William M Grady; Ajay Goel
Journal:  Gastroenterology       Date:  2015-07-26       Impact factor: 22.682

10.  Multifaceted enrichment analysis of RNA-RNA crosstalk reveals cooperating micro-societies in human colorectal cancer.

Authors:  Tommaso Mazza; Gianluigi Mazzoccoli; Caterina Fusilli; Daniele Capocefalo; Anna Panza; Tommaso Biagini; Stefano Castellana; Annamaria Gentile; Angelo De Cata; Orazio Palumbo; Raffaella Stallone; Rosa Rubino; Massimo Carella; Ada Piepoli
Journal:  Nucleic Acids Res       Date:  2016-04-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.